If our current findings are confirmed and deepened by other studies to gain a better comprehension of the molecular effects of GALNT2 on insulin sensitivity, this will likely become instrumental in the discovery of hitherto unknown pathogenic nodes that can be targeted with new therapies in patients with insulin resistance and related anomalies. This evidence concerns the gene GALNT2 and Insulin resistance.